Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
177Lu-PSMA-1 in Metastatic Clear Cell Renal Cancer
NCT06059014Phase 2Completed
- Sponsor
- Centre Léon Bérard
- Start
- Nov 2023
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lutetium Lu 177 PSMA I&T in clear cell renal cell carcinoma (ccRCC), sponsored by Centre Léon Bérard. Started Nov 2023; status: completed.
02
Drugs
lutetium Lu 177 PSMA I&T
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT06059014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06059014.